Early tumor response to Hsp90 therapy using HER2 PET: Comparison with 18F-FDG PET Academic Article uri icon

Overview

MeSH Major

  • Fluorodeoxyglucose F18
  • HSP90 Heat-Shock Proteins
  • Positron-Emission Tomography
  • Receptor, ErbB-2

abstract

  • HER2 PET is an earlier predictor of tumor response to 17AAG therapy than (18)F-FDG PET.

publication date

  • May 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3193602

PubMed ID

  • 16644749

Additional Document Info

start page

  • 793

end page

  • 6

volume

  • 47

number

  • 5